This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Cryoport, Inc. ("Company"), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, announced the launch of a new logistics service supporting complete facility relocation of critical cryogenically frozen sample collections.
Cryoport is providing complete logistics management for the relocation of a leading research laboratory and IVF clinic, with all material shipping and transport supervised and performed by trained personnel under compliance with DOT, CDC and IATA regulations.
The relocation of a laboratory or clinic is a significant and complex endeavor consisting of valuable and irreplaceable research samples such as cell lines, DNA, and other biological samples such as an individual's reproductive material critical for family creation. The critical nature of these samples requires full regulatory knowledge under an umbrella of exact environmental conditions for the transfer. Cryoport has the best-in-class logistics solutions and possesses the expertise in handling to safely and successfully relocate cryogenically frozen samples without error.
Jerrell Shelton, Cryoport's CEO, stated, "We are uniquely suited to support the wholesale movement of critical laboratory samples that require strict conditions from one location to another in a controlled manner. The fact that institutions and clinics trust their entire life's work to our care is a testament to our validated cryogenic logistics solutions paired with our experience and knowledge in supporting such relocations. We look forward to further collaboration with leading research centers and other organizations in their relocation over the coming months."
>> For more information, click here
